---
title: "4D Molecular Therapeutics CEO David Kirn disposes of common shares worth $1,068,651.63"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296648682.md"
description: "4D Molecular Therapeutics CEO David Kirn sold 69,076 shares on August 19, 2026, at prices between $15.36 and $16.42, totaling approximately $1.07 million. He simultaneously exercised options for 50,000 shares at $4.14. Following these transactions, his direct shareholding stood at 825,819 shares."
datetime: "2026-08-21T20:07:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296648682.md)
  - [en](https://longbridge.com/en/news/296648682.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296648682.md)
generator: "portal-rs"
---

# 4D Molecular Therapeutics CEO David Kirn disposes of common shares worth $1,068,651.63

-   4D Molecular Therapeutics CEO David Kirn sold 69,076 shares on Aug. 19, 2026 at weighted average prices of USD 15.36 to USD 16.42. \* He exercised options to acquire 50,000 shares at USD 4.14 on the same day. \* Kirn’s direct holding ended the day at 825,819 shares. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 4D Molecular Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-361096), on August 21, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [FDMT.US](https://longbridge.com/en/quote/FDMT.US.md)

## Related News & Research

- [4D Molecular Therapeutics posts corporate presentation highlighting AAV gene therapy pipeline led by 4D-150 for wet AMD, DME](https://longbridge.com/en/news/296635019.md)
- [4D Molecular Therapeutics CEO David Kirn sells USD 739,829 in common shares](https://longbridge.com/en/news/292676162.md)
- [Camtek CEO Amit Rafi disposes of 6,250 shares for $1.07 million](https://longbridge.com/en/news/296101536.md)
- [Green Minerals grants 150,000 share options to director Stig Myrseth at NOK 2 strike](https://longbridge.com/en/news/296438187.md)
- [Kona BidCo raises Zalaris stake to 87.34% after buying 2,337 shares at NOK 100 apiece](https://longbridge.com/en/news/296256150.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**